Answers are grounded in this paper and cite their sources.
Glymphatic system dysfunction is implicated in cardiovascular diseases. Near-infrared window II (NIR-II) fluorescence imaging has emerged as a promising tool for studying cerebrospinal fluid (CSF) transport within the glymphatic system. However, current NIR-II methods still suffer from suboptimal contrast and are often confined to local CSF transport, making it difficult to achieve detailed observations of whole-body CSF dynamics in living animals. Here, we first reported a phenomenon that has received little attention in previous glymphatic imaging studies: indocyanine green (ICG)—a clinically approved dye—undergoes marked aggregation-induced fluorescence quenching in CSF, driven by both its high ionic strength and its low protein concentration. To overcome this quenching, we engineered an albumin-based NIR-II nanoprobe (ICG@BSA) with optimized photophysical properties and colloidal stability, yielding a physiologically relevant, bright, and stable CSF tracer. Using this nanoprobe, we achieved in vivo tracking of CSF tracer clearance—from perivascular influx in ~ 60-µm-wide vessels to systemic efflux and subsequent metabolism in mice and rats with significantly enhanced imaging contrast. Crucially, using both isoflurane anesthesia-induced hypothermia and a propranolol-induced bradycardia and hypotension model, we observed an association between cardiovascular suppression and altered tracer clearance rate, potentially involving impaired lymphatic dynamics. These findings suggest a link between hemodynamic states, lymphatic function, and brain waste clearance efficiency, providing evidence for systemic modulation of brain metabolic waste.
No takes yet. Share an insight, caveat, or question.
Jiang et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: